Related Experiment Video

Updated: May 12, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Diabetes and Cardiovascular Disease: Original Insights from the Framingham Heart Study

Mohammad U Qazi1, Shaista Malik

  • 1Department of Medicine, University of California, Irvine.

Global Heart
|April 2, 2013
PubMed

Insights

Diabetes significantly increases cardiovascular disease (CVD) risk, especially in women. Landmark studies, including the Framingham Heart Study, identified key risk factors like smoking and hypertension, guiding CVD prevention strategies.

Area of Science:

  • Cardiology
  • Endocrinology
  • Epidemiology

Background:

  • Cardiovascular disease (CVD) pathogenesis in diabetic patients was initially unclear.
  • The 1979 Kannel et al. study using Framingham Heart Study (FHS) data identified diabetes as a major CVD risk factor.
  • Early research highlighted a disproportionately higher CVD risk in women with diabetes compared to men.

Purpose of the Study:

  • To review the foundational contribution of the Kannel article to understanding diabetes and CVD.
  • To examine how subsequent research has defined multiple cardiovascular risk factors.
  • To synthesize the impact of various risk factors on cardiovascular disease development.

Main Methods:

  • Review of seminal research, including the Framingham Heart Study data.
  • Analysis of epidemiological studies identifying and quantifying cardiovascular risk factors.
  • Synthesis of evidence on the interplay between diabetes and other CVD risk factors.

Main Results:

  • Diabetes is established as a significant independent risk factor for cardiovascular disease.
  • Specific risk factors like smoking, obesity, hypertension, hyperlipidemia, and insulin resistance have been identified and quantified.
  • Differential CVD risk between diabetic men and women has been consistently observed.

Conclusions:

  • The Kannel et al. study was pivotal in establishing diabetes as a critical cardiovascular risk factor.
  • Ongoing research continues to refine our understanding and management of multifactorial CVD risk.
  • Effective CVD prevention requires addressing diabetes and associated metabolic and lifestyle factors.

More Related Videos

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans08:21

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans

Published on: July 21, 2023

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...